{
    "title": "Individual feed for http://feeds.benzinga.com/benzinga",
    "link": "http://feeds.benzinga.com/benzinga",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-10-07T11:12:22.620067",
    "items": [
        {
            "title": "Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields",
            "link": "https://www.benzinga.com/trading-ideas/dividends/25/10/48071443/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-with-over-6-d",
            "description": "read more",
            "pubDate": "2025-10-07T12:56:50",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/10/07/Real-Estate-Builds-Long-Term-Equity.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "This Spire Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday",
            "link": "https://www.benzinga.com/analyst-stock-ratings/initiation/25/10/48071399/this-spire-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-",
            "description": "read more",
            "pubDate": "2025-10-07T12:49:49",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/10/07/Side-View-Of-Concentrated-Crypto-Trader-.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "EXCLUSIVE: Envoy Medical Cuts Capital Needs After FDA Approval For Final Trial Stage Of Cochlear Implant Trial",
            "link": "https://www.benzinga.com/news/health-care/25/10/48071376/exclusive-envoy-medical-cuts-capital-needs-after-fda-approval-for-final-trial-stage-of-cochlear-",
            "description": "Envoy Medical secured FDA approval to expand its Acclaim cochlear implant trial, accelerating timelines and reducing capital needs by up to $15 millio...",
            "pubDate": "2025-10-07T12:46:08",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/10/07/Medical-Development-Laboratory-Caucasian.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "This Netflix Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday",
            "link": "https://www.benzinga.com/analyst-stock-ratings/upgrades/25/10/48071342/this-netflix-analyst-turns-bullish-here-are-top-4-upgrades-for-tuesday",
            "description": "read more",
            "pubDate": "2025-10-07T12:42:34",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/10/07/Netflix-Faces-UOKiK-Fines.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "The Case for NCIQ ETF: A Rules-Based Approach To Multi-Asset Crypto Investing",
            "link": "https://www.benzinga.com/Opinion/25/10/48071326/the-case-for-nciq-etf-a-rules-based-approach-to-multi-asset-crypto-investing",
            "description": "read more",
            "pubDate": "2025-10-07T12:40:16",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png"
        }
    ]
}